DDI-DrugBank.d619.s0 >> The occurrence of stupor, muscular rigidity, severe agitation, and elevated temperature has been reported in some patients receiving the combination of selegiline and meperidine. >> 152-161,167-176
DDI-DrugBank.d619.s1 >> Symptoms usually resolve over days when the combination is discontinued.
DDI-DrugBank.d619.s2 >> This is typical of the interaction of meperidine and MAOIs. >> 38-47,53-57
DDI-DrugBank.d619.s3 >> Other serious reactions (including severe agitation, hallucinations, and death) have been reported in patients receiving this combination.
DDI-DrugBank.d619.s4 >> Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and ELDEPRYL and selective serotonin reuptake inhibitors and ELDEPRYL. >> 80-104,110-117,123-161,167-174
DDI-DrugBank.d619.s5 >> One case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication (ephedrine). >> 95-104,112-137,140-148
